Search Results 451-460 of 16238 for pharmacogenetics
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Researchers in this brain focus area of the Discovery and Translation Labs at Mayo Clinic focus on translational research related to biomarker and drug ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
Develop a biobank of samples from patients undergoing therapy with PCSK9 inhibitors (FDA- approved in 2015, therapeutics for hypercholesterolemia) with the goal ...
Learn about services and treatment options, including a residential treatment program, for people who want to stop smoking or live tobacco- or nicotine ...
The Development Technologist Track is designed for technically skilled technologists with several years of experience in the clinical laboratories. These ...
Some women report relief from endometriosis pain after acupuncture treatment. However, research is sparse on this — or any other — alternative treatment for ...
Propionic acidemia (PA) is a metabolic genetic disease that occurs in 1 in 35,000 live births in the United States. This disease causes metabolic acidosis, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.